Publication | Closed Access

Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors

Medicinal ChemistryNatural SciencesAntiproliferative EgfrDiversity-oriented SynthesisMedicineBrafv600e Dual InhibitorsOrganic ChemistryAnti-cancer AgentPharmacologyPharmaceutical ChemistryBiomolecular EngineeringDrug Discovery